| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -3.1e-05 | 1 |